RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relay Therapeutics (RLAY) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $21.00 price target on the stock.
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival [Yahoo! Finance]
Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Form 4 Relay Therapeutics, Inc. For: Dec 16 Filed by: Patel Sanjiv
Form 144 Relay Therapeutics, Inc. Filed by: Patel Sanjiv
Form 8-K Relay Therapeutics, Inc. For: Dec 11
Form SC 13G/A Relay Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form 10-Q Relay Therapeutics, Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.